2023 News Releases

W. Kimryn Rathmell begins work as 17th director of the National Cancer Institute

• December 18, 2023

NCI researchers develop approach that could help supercharge T-cell therapies against solid tumors

• November 1, 2023

NIH immunotherapy pioneer Steven Rosenberg awarded nation’s highest honor for technology and innovation

• October 24, 2023

Annual Report to the Nation Part 2: New cancer diagnoses fell abruptly early in the COVID-19 pandemic

• September 27, 2023

NCI unveils comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

• August 14, 2023

NIH study offers insights into how cells reverse their decision to divide

• July 5, 2023

Biden-Harris Administration launches initiative to improve cancer outcomes in low-income areas

• June 26, 2023

NCI’s ComboMATCH initiative will test new drug combinations guided by tumor biology

• June 1, 2023

NCI study outlines opportunities to achieve President Biden’s Cancer Moonshot goal of reducing cancer death rates in the United States

• April 17, 2023

Pragmatica-Lung Study, a streamlined model for future cancer clinical trials, begins enrolling patients

• April 12, 2023

NCI study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis

• April 4, 2023

Cancer Grand Challenges announces global research funding opportunity with nine new challenges

• March 8, 2023